Colchicine and Gemcitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colchicine (colchicine) and Gemcitabine (gemcitabine). Common drug interactions include nausea among females and bile duct stenosis among males.

The phase IV clinical study analyzes what interactions people have when they take Colchicine and Gemcitabine. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Colchicine?

Colchicine has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 21,826 Colchicine users. Check the latest studies of Colchicine.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

On Jul, 31, 2026

29 people who take Colchicine and Gemcitabine together, and have interactions are studied.

Colchicine and Gemcitabine drug interactions.

What are the common drug interactions of Colchicine and Gemcitabine, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Vomiting
Abdominal pain lower
Abnormal faeces (abnormal stool)
Anorectal discomfort
Constipation
Haematochezia (passage of stools containing blood)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Leukocytosis (increased white blood cells)
Night sweats (sweating in night)

male:

Bile duct stenosis (abnormal narrowing of the common bile duct)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Dyspnoea (difficult or laboured respiration)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypotension (abnormally low blood pressure)
Oedema (fluid collection in tissue)
Oedema peripheral (superficial swelling)
Pyrexia (fever)
Septic shock (shock due to blood infection)
Swelling face

What are the common drug interactions of Colchicine and Gemcitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Dyspnoea (difficult or laboured respiration)
Pericardial effusion (fluid around the heart)
Swelling face

30-39:

n/a

40-49:

n/a

50-59:

Hypotension (abnormally low blood pressure)
Septic shock (shock due to blood infection)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Cardiac tamponade (fluid accumulates in heart covering)
Drug intolerance (drug sensitivity)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Leukopenia (less number of white blood cells in blood)
Nausea (feeling of having an urge to vomit)
Renal failure (kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)

60+:

Bile duct stenosis (abnormal narrowing of the common bile duct)
Abdominal pain lower
Night sweats (sweating in night)
Oropharyngeal pain
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Vomiting
Anaemia (lack of blood)
Disease progression
Myelosuppression (a decrease in the production of blood cells)

What are the existing conditions these people have? *

Constipation: 8 people, 27.59%
High Blood Pressure: 6 people, 20.69%
Pain: 6 people, 20.69%
Nausea (feeling of having an urge to vomit): 6 people, 20.69%
Splenic Vein Thrombosis (blood clot in splenic vein): 4 people, 13.79%
Nausea And Vomiting: 4 people, 13.79%
Stress And Anxiety: 4 people, 13.79%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 4 people, 13.79%
Pancreatic Carcinoma (pancreatic cancer): 3 people, 10.34%
Hepatocellular Carcinoma (liver cancer): 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Colchicine and Gemcitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously